GlassScriptPhysician profile
Madison M Petty
NPI 1205545761
$1,997.88
in general payments reported to CMS, 2019-2025
28 companies · $1,598 in 2025
The $1,598 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $113 · 2024: $287 · 2025: $1,598.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,998.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,997.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $302.61 | 2023-2025 | Erleada, Tremfya, Stelara |
| Bayer Healthcare Pharmaceuticals INC. | $268.30 | 2025 | |
| Abbvie INC. | $149.78 | 2023-2025 | |
| Pfizer INC. | $137.08 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $88.70 | 2025 | Welireg, Keytruda, Keytruda Qlex |
| Takeda Pharmaceuticals U.S.A., INC. | $86.27 | 2023-2024 | Eohilia, Entyvio |
| Telix Pharmaceuticals | $84.76 | 2025 | Illuccix |
| Sumitomo Pharma America, INC. | $80.25 | 2025 | Gemtesa |
| Urogen Pharma, INC. | $79.85 | 2025 | |
| Dendreon Pharmaceuticals LLC | $77.80 | 2025 | Provenge |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $73.55 | 2024-2025 | Xifaxan |
| Aimmune Therapeutics, INC. | $69.47 | 2024-2025 | Zenpep |
| Antares Pharma, INC. | $61.85 | 2025 | Xyosted |
| Endo USA, INC. | $45.02 | 2025 | Xiaflex |
| Ironwood Pharmaceuticals, INC | $41.56 | 2024 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $39.94 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $38.71 | 2023-2025 | Adstiladrin, Rebyota |
| 180 Medical, INC. | $34.82 | 2025 | Gentlecath Glide |
| Teleflex LLC | $31.89 | 2025 | Urolift |
| Novartis Pharmaceuticals Corporation | $30.65 | 2025 | |
| Olympus America INC. | $29.91 | 2025 | Itind System |
| Immunitybio, INC. | $27.88 | 2025 | |
| Coloplast Corp | $25.76 | 2025 | |
| Astellas Pharma US INC | $24.18 | 2025 | Xtandi |
| Karl Storz Endoscopy-America | $23.60 | 2025 | |
| Abc Home Medical Supply, INC. | $14.70 | 2025 | |
| Braintree Laboratories, INC. | $14.55 | 2024 | Suflave, Sutab |
| Blue Earth Diagnostics | $14.44 | 2025 | Posluma |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madison Petty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.